FDA OKs First New P Vivax Malaria Treatment in 60 Years
July 24th 2018The FDA has approved, under Priority Review, GlaxoSmithKline (GSK)’s tafenoquine (Krintafel), which is the first single-dose medicine for the prevention of Plasmodium vivax (P vivax) malaria relapse in patients over the age of 16 years who are receiving antimalarial therapy.
Read More
Asthma Control Linked to Atrial Fibrillation Risk
July 23rd 2018A new research study, published in JAMA Cardiology, aimed to further confirm a previous correlation between asthma and atrial fibrillation (AF) and to determine if the degree of asthma control affected the risk of developing AF.
Read More